Mathi Mathivanan

Title: The Innovations of Mathi Mathivanan

Introduction

Mathi Mathivanan is a notable inventor based in Markham, Canada. He has made significant contributions to the field of pharmaceutical sciences, particularly in the stabilization of azithromycin compositions. His work has implications for improving the efficacy and shelf-life of important medications.

Latest Patents

Mathi Mathivanan holds a patent for "Stabilized azithromycin compositions." This patent describes compositions and methods for stabilizing azithromycin, which is crucial for maintaining its effectiveness. The stabilized compositions consist of an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant. This innovation enhances the resistance of azithromycin to degradation, ensuring that it remains effective for longer periods. The methods of achieving this intimate admixture include coprecipitation or co-milling of azithromycin and an antioxidant. Additionally, the patent outlines pharmaceutical formulations that incorporate these stabilized compositions and the methods for creating them.

Career Highlights

Mathi Mathivanan is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions to enhance drug formulations. His expertise in stabilizing pharmaceutical compounds has positioned him as a valuable asset in the industry.

Collaborations

Mathi has collaborated with Ruth Tenengauzer, a fellow professional in the pharmaceutical field. Their partnership has contributed to advancements in drug formulation and stabilization techniques.

Conclusion

Mathi Mathivanan's work in stabilizing azithromycin compositions showcases his innovative spirit and dedication to improving pharmaceutical formulations. His contributions are vital for enhancing the effectiveness of medications, ultimately benefiting patients worldwide.